Aris P. Agouridis

Rosuvastatin treatment is associated with an increase in insulin resistance in hyperlipidaemic patients with impaired fasting glucose

Michael S. Kostapanos, Haralambos Milionis, Aris P. Agouridis et al. · International Journal of Clinical Practice · 2009 · 54 citations

Ear lobe crease: a marker of coronary artery disease?

Aris P. Agouridis, Moses Elisaf, Devaki Nair et al. · Archives of Medical Science · 2015 · 39 citations · Full text

Vascular Disease, Cardiovascular Disease, Ophthalmology +12

The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemia

Aris P. Agouridis, Vasilis Tsimihodimos, Theodosios D. Filippatos et al. · Expert Opinion on Pharmacotherapy · 2011 · 33 citations

Effect of rosuvastatin monotherapy or in combination with fenofibrate or ω-3 fatty acids on lipoprotein subfraction profile in patients with mixed dyslipidaemia and metabolic syndrome

Aris P. Agouridis, Michael S. Kostapanos, Vasilis Tsimihodimos et al. · International Journal of Clinical Practice · 2012 · 25 citations

High Doses of Rosuvastatin are Superior to Low Doses of Rosuvastatin Plus Fenofibrate or n‐3 Fatty Acids in Mixed Dyslipidemia

Aris P. Agouridis, Vasilis Tsimihodimos, Theodosios D. Filippatos et al. · Lipids · 2011 · 23 citations